Editorial
Multimodality therapy for locally-advanced thymic epithelial tumors: where are we now?
Abstract
The interest on surgical management of thymic neoplasms has never been so evident as in the last few years, following the publication of several multi-institutional large series, especially thanks to a formidable scientific effort by the European Society for Thoracic Surgeons (ESTS) and the International Thymic Malignancy Interest Group (ITMIG) (1-6).
